NYSEAMERICAN : APUS
Apimeds Pharmaceuticals US, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic · United Arab Emirates
Last price 3.1 USD (Oct 30, 2026, 9:31 AM EDT) · Market cap 4.68M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.